BioCentury
ARTICLE | Product Development

AAV COVID-19 vaccine aims for the sweet spot between antibody and T cell immunity

The rationale behind the only AAV-based vaccine in development for COVID-19

June 6, 2020 1:21 AM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article